Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: Data from the Brisighella heart study

Advances in Clinical and Experimental Medicine

Volumn 22, Issue 1, 2013, Pages 69-76

  Cicero, Arrigo F G ^a   Reggi, Alessandra ^a   Tartagni, Elisa ^a   Grandi, Elisa ^a   D'Addato, Sergio ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dietary habit; Epidemiology; Nutritional determinants; Ox LDL Ab

Indexed keywords

COPPER; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; ZINC;

AGE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIET; ENERGY YIELD; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY;

EID: 84875854408     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mitra S, Goyal T, Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 2011, 25(5), 419-429.
2. Hansson GK, Hermansson A: The immune system in atherosclerosis. Nat Immunol 2011, 12(3), 204-212.
3. Steinerová A, Racek J, Stozický F, Zima T, Fialová L, Lapin A: Antibodies against oxidized LDL - theory and clinical use. Physiol Res 2001, 50(2), 131-141. (Pubitemid 32523435)
4. Oranje WA, Wolffenbuttel BHR: Lipid peroxidation and atherosclerosis in type II diabetes. J Lab Clin Med 1999, 134, 19-32. (Pubitemid 29332167)
5. Cojocaru IM, Cojocaru M, Burcin C: IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset. Rom J Intern Med 2006, 44(2), 165-170.
6. Rouhl RP, van Oostenbrugge RJ, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, Kroon AA, de Leeuw PW, Lodder J, Tervaert JW, Damoiseaux JG: Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease. Stroke 2010, 41(11), 2687-2689.
7. Swets BP, Brouwer DA, Tervaert JW: Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin Exp Immunol 2001, 124(1), 163-167. (Pubitemid 32476947)
8. Laczik R, Szodoray P, Veres K, Szomják E, Csípo I, Sipka S Jr, Shoenfeld Y, Szekanecz Z, Soltész P: Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome. Lupus 2011, 20(7), 730-735.
9. Che J, Li G, Wang W, Li Q, Liu H, Chen K, Liu T: Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Cardiol J 2011, 18(4), 364-370.
10. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK: Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998, 102, 910-918. (Pubitemid 28419236)
11. Schiopu A, Frendeus B, Jansson B, Söderberg I, Ljungcrantz I, Araya Z, Shah PK, Carlsson R, Nilsson J, Fredrikson GN: Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol 2007, 50, 2313-2318. (Pubitemid 350199611)
12. Liu CS, Lii CK, Ou CC, Tsai CH, Wei YH, Chen HW: Autoantibody against oxidized low-density lipoproteins may be enhanced by cigarette smoking. Chem Biol Inter 2000, 127 (2), 125-137.
13. Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P: Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 2003, 57 (2), 383-387. (Pubitemid 36240495)
14. Descovich GC, Cavallo G, Mannino G, Lenzi S: The Brisighella survey: a study of dietary habits. Minerva Med 1983, 74(11), 547-555. (Pubitemid 13128030)
15. Ardigò D, Bernini F, Borghi C et al. on behalf of the ADSL project investigators: Advanced diagnostic support in lipidology project: role for phenotypic and functional evaluation of lipoproteins in dyslipidemias. Clin Lipidol 2010, 5(3), 329-337.
16. Cicero AFG, Dormi A, D'Addato S, Borghi C on behalf of the Brisighella Heart Study Staff: From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study. Clin Lipidol 2011, 6(3), 269-276.
17. Gaddi A, Cicero AF, Wani FO, Dormi A, Pasquarelli V, D'Addato S: The realization of a project aimed at reducing the plasmatic lipid level in a large Italian population improves the mean calcium daily intake: the Brisighella Study. Eur J Clin Nutr 2001, 55(2), 97-106. (Pubitemid 32156889)
18. Tatzber F, Esterbauer H: Autoantibodies to oxidized low density lipoprotein. In: Free Radicals, Lipoprotein Oxidation and Atherosclerosis. Eds.: Bellomo G, Finardi G, Maggi E, Rice-Evance C. London, UK: Richelieu Press: 1995, 245-262.
19. Castańer O, Fitó M, López-Sabater MC et al. EUROLIVE Study Group: The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin Nutr 2011, 30(4), 490-493.
20. Miller AA, De Silva TM, Jackman KA, Sobey CG: Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 2007, 34(10),1037-1043. (Pubitemid 47274564)
21. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1993, 328, 1069-1075. (Pubitemid 23097795)
22. Frezza M, Di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism. N Engl J Med 1990, 322, 95-99. (Pubitemid 20023867)
23. Di Bari M, Zacchei S, Kritchevsky SB, Kritchevsky SB, Anichini M, Cesaretti S, Chiarlone M, Masotti G, Marchionni N: Anti-oxidized LDL antibodies and wine consumption: a population-based epidemiological study in Dicomano, Italy. Ann Epidemiol 2003, 13(3), 189-195. (Pubitemid 36258408)
24. Wen Y, Killalea S, Norris LA, Cooke T, Feely J: Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation. Eur J Clin Invest 1999, 29(12), 1027-1034.
25. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME: Zinc and human health: an update. Arch Toxicol 2012, 86(4), 521-534.
26. Yang YJ, Choi BY, Chun BY, Kweon SS, Lee YH, Park PS, Kim MK: Dietary zinc intake is inversely related to subclinical atherosclerosis measured by carotid intima-media thickness. Br J Nutr 2010, 104(8), 1202-1211.
27. Islamoglu Y, Evliyaoglu O, Tekbas E, Cil H, Elbey MA, Atilgan Z, Kaya H, Bilik Z, Akyuz A, Alan S: The relationship between serum levels of Zn and Cu and severity of coronary atherosclerosis. Biol Trace Elem Res 2011, 144(1-3), 436-444.
28. Ghayour-Mobarhan M, Taylor A, Kazemi-Bajestani SM, Lanham-New S, Lamb DJ, Vaidya N, Livingstone C, Wang T, Ferns GA: Serum zinc and copper status in dyslipidaemic patients with and without established coronary artery disease. Clin Lab 2008, 54(9-10), 321-329.
29. de Oliveira Otto MC, Alonso A, Lee DH, Delclos GL, Bertoni AG, Jiang R, Lima JA, Symanski E, Jacobs DR Jr, Nettleton JA: Dietary intakes of zinc and heme iron from red meat, but not from other sources, are associated with greater risk of metabolic syndrome and cardiovascular disease. Am J Nutr 2012, 142(3), 526-533.